logo-education
0370 270 6000

already registered?

Please sign in with your existing account details.

need to register?

Register to access exclusive content, sign up to receive our updates and personalise your experience on brownejacobson.com.

Privacy statement - Terms and conditions

Forgotten your password?

Implementation of EMA’s replacement criticised

19 July 2011

The government announced back in October that the Education Maintenance Allowance (EMA) which provided means-tested grants of up to £30 a week to help young people stay on at school or college was to be scrapped. The £180 million fund which is to replace the scheme would instead be allocated by colleges at their own discretion.

An MP select committee, whilst recognising the need to scrap the EMA, has criticised the execution of its replacement. Colleges did not receive their allocations until June which is too late for this year’s cohort of 15-16 year olds starting courses in September. Most would have submitted their applications well in advance.

The new scheme has also come in for criticism and is likely to result in wide ranging inconsistencies. Savvy colleges may be able to use the fund to attract more students defeating the overall aim of the fund, that is to support those most in need. This is not likely to be the last we hear of the new bursary fund.

Related opinions

Does the move into Step 4 mean the ending of Covid-19 restrictions within schools?

With the Prime Ministers announcement that he intends for Step 4 to begin on 19 July, this will also bring an end to the restrictions currently in place on education settings.

View blog

Advocacy in Action: Female Genital Mutilation Protection Orders (FGMPO)

The issue of Female Genital Mutilation Protection Orders and the importance of education providers to act promptly.

View blog

Responsibilities towards students identifying as non-binary

Our top tips for supporting transgender and non-binary pupils.

View blog

Schools face scrutiny over Covid-19 vaccinations for children

On 4 June, the Medicines and Healthcare products Regulatory Agency (MHRA) approved the use of the Pfizer/BioNTech Covid-19 vaccine for 12- to 15-year-olds.

View blog

Mailing list sign up

Select which mailings you would like to receive from us.

Sign up